Source Orphan Drugs Experts for your Project, Phone Consult or Job

Submit an anonymous Inquiry -- Start receiving responses within a few hours

Have a need? Explain it here

Zintro does not display, sell or trade e-mail addresses

An eye iconForgot password?
Submit Inquiry

By clicking Submit Inquiry you agree to our TermsVIEW

or Request Pricing Information

How Zintro Works

  1. 1. Provide a clear description of your needs and your expectations of an expert, consultant or job candidate and Zintro will match it with the most relevant professionals in our platform.
  2. 2. Within a day or two typically 6 - 12 Experts, who have opted-in, will contact you with a brief explanation of their qualifications and how they can help.
  3. 3. You can communicate back and forth, qualify each other, connect and pay fees to Experts through Zintro.
  4. Zintro is free, anonymous and without obligation.

Loved by Thousands

Loved by thousands logos

Need Help?A phone icon1-877-236-7016

Recent Orphan Drugs Inquiries

Area Icon

Orphan Drug

We are currently looking to understand the pharma distribution strategy adopted by orphan drug (drugs to treat rare disease) manufacturers in australia. We know that australian market is dominated by three major cso distributors (api, sigma and x b) and major generic drug manufacturers prefer to engage with these 3 wholesalers as they have the maximum distribution point of sales and are required to supply drugs listed in pbs. 1. So based on this, would like to know if orphan drug manufacturers also use these wholesalers or do they prefer direct distribution using dhl or world couriers, or any other strategy? 2. Would like to get some case specific to orphan drug distribution in australia. Thank you and looking forward.

    +undefined Other Responses
    Area Icon

    Orphan Drug Reimbursement

    Looking to interview 3 experts from the managed care industry, employed by health plans, and having experience on reimbursement issues for orpahn drugs for rare diseases

    1. Profile Picture

      David |Principal

      I have 15 yrs of Managed care experience, currently serve on a P and T committee and do approval an...

      5.2 Hours Later
    2. Profile Picture

      jan |Medico-Marketing European Strategist

      My profile may interest you for my expertise in your field. Please contact me through zNote. Lookin...

      13 Hours Later
    3. Profile Picture

      Javier |Clinical Pharmacist, Consultant Pharmaci

      PBM's are managed care ***** :) We are the ones that handle and process the claims. PBM's ha...

      1 Day Later
    +16 Other Responses
    Area Icon

    Creative Services For Pharmaceuticals

    Creative and digital agency for pharmaceuticals sourcing strategy - what is the best sourcing model for creative and digital services for pharmaceutical companies? - what is the sourcing approach followed typically by leading pharmaceutical companies? (full-service model or specialized agency model)? - do large pharma/vaccines companies bundle digital and creative work to single agencies? Pricing models - what is the most optimal pricing model while engaging with digital and creative agencies to assure transparency and control of costs? - is fixed price or performance based pricing or any other? - i would like to understand if fixed price model is most effective pricing model to control costs while engaging with creative and digital agencies.

    1. Profile Picture

      Bob |Creative Director/Strategist

      I have consulted brands on the budget and ***** marketing and advertising *****...

      40 Minutes Later
    2. Profile Picture

      Camille |CEO of Online Business Services Provider

      To answer some of your questions I would need to be more familiar with your particular constraints; ...

      1.8 Hours Later
    3. Profile Picture

      C. Yume |Digital Project Manager, Digital Produce

      I'll give you a tip from working for Digital Agencies many years before becoming a digital consultan...

      1.9 Hours Later
    +10 Other Responses
    Area Icon

    Pharmaceutical Manufacturing

    Looking for experts for pharmaceutical manufacturing as small unit. How can i start.

    1. Profile Picture

      Aloysius |President

      BREEJ Technologies Consulting Group offers Consulting Services to the Pharmaceutical and Personal Ca...

      14 Minutes Later
    2. Profile Picture

      L |Food Safety SQF Consultant

      I would need to know what type of pharmaceuticals you plan to produce....

      28 Minutes Later
    3. Profile Picture

      Matthew |Consultant

      Undertaken multiple consulting projects for the pharma industry. I would be happy to guide you throu...

      1.8 Hours Later
    +28 Other Responses
    Area Icon

    Orphan Drug

    Topic: orphan drug space we are a global research firm and an authorized zintro partner looking for experts who could consult for a study on the orphan drug space in europe and americas. Ideal candidates would be medical doctors, pharmaceutical professionals, and/or regulatory experts. If interested, please briefly describe your experience in this space, and the disease areas you are most familiar with. The expert needs to be available to consult with us via phone consultations. If interested, please contact me. Thanks!

    1. Profile Picture

      Jukka |President, Director

      I have been involved in orphan drug development in almost 10 TAs over 30 years in Europe, US and Can...

      58 Minutes Later
    2. Profile Picture

      Eugene |Scientific Director

      Dear Colleagues, I'm expert in pharma. 16 + years. Advisor for pharma companies. also have MD and ma...

      1.4 Hours Later
    3. Profile Picture

      Barry |Principal, Barry Garfinkle & Associates

      I have extensive experience in Biologics and small molecule drug manufacture and tech transfer. I w...

      2.5 Hours Later
    +13 Other Responses
    Area Icon

    Pharmaceuticals, Vaccines And Consumer Products Distribution

    "pharmaceuticals, vaccines and consumer products-distribution sourcing" geography: europe 1. Sourcing best practice a. What are the sourcing approaches followed by global organizations when dealing with distributors/wholesalers across pharmaceutical, consumer and vaccine business? (centralized/decentralized) 2. Engagement best practice a. What is the best practice followed by companies when engaging for distribution services across pharmaceutical, consumer and vaccine business? I. Is it engaging with a distributor or wholesaler? · global/regional/local distributors? · single or multiple distributors? 3. Feasibility of integrating the distribution model for pharmaceuticals, consumer and vaccine business a. How do companies with multiple business units such as pharmaceutical, consumer and vaccine business manage this category? I. Is there a chance of integrating the distribution of these three business units with single set of distributors? Ii. What are the advantages and disadvantages of following the integration approach?

    1. Profile Picture

      Debasish |HEAD SUPPLY CHAIN

      Please refer my profile...

      6.6 Hours Later
    2. Profile Picture

      Eugene |Scientific Director

      Hello. I can help. I'm GDP Expert, Director of CRO and ex Marketing Director in Big Pharma....

      6.7 Hours Later
    3. Profile Picture

      Polina |Zintro Expert

      I can speak from a procurement perspective. Would you like to schedule a call for next week?...

      7.7 Hours Later
    +9 Other Responses
    Area Icon

    Us Pharmaceutical Manufacturing

    Our us firm requires us experts in pharmaceutical manufacturing, ideally someone familiar with testing procedures, production lines and the equipment used to monitor production of common pharmaceuticals (pills / tablets.) - we prefer someone with a technical or manufacturing / operations (e.G., quality control) background. Referrals are also welcomed, thank you.

      +undefined Other Responses
      Area Icon

      Pharmaceutical Taste Masking

      Established pharmaceutical company wants to outsource formulation and gmp manufacture of rapid dissolving and bitter taste masking tablet for sublingual use. Need experts in taste masking formulations.

      1. Profile Picture

        jeevan |Deputy Manager formulation R&D

        kindly let me know the details...

        15 Minutes Later
      2. Profile Picture

        Jisheng |Professional formulation consultant

        I can help you with my over 14 years of pharmaceutical *****rience. I have developed seve...

        19 Minutes Later
      3. Profile Picture

        Aloysius |President

        BREEJ Technologies Consulting Group offers Consulting Services to the Pharmaceutical and Biotechnolo...

        2 Hours Later
      +7 Other Responses
      Area Icon

      Rare Disease Generics

      I am looking to speak with knowledgeable contacts in the pharmaceutical industry with experience in the area of rare disease generics. I am interested to learn about companies such as par pharmaceuticals, hetero, and apotex who are developing generics in the rare disease space. The knowledge source should have an understanding of the mentioned generic company’s capabilities.

        +undefined Other Responses
        Area Icon

        Pharmaceutical Contract Sales

        Project : study on pharmaceutical companies sourcing sales reps from contract sales organizations industry: pharmaceuticals, contract sales scope: australia, belgium, netherlands, saudi arabia, puerto rico, venezuela. We are doing a project on procuring sales force from contract sales organizations in various markets. Request expert guidance in understanding the procurement best practices followed by leading pharmaceutical companies while sourcing contract sales reps from contract sales organizations

        1. Profile Picture

          Shyam |VP of Finance

          Just completed a major contract sales *****y for a large global procurement consulting f...

          41 Minutes Later
        2. Profile Picture

          Rita |Principle

          Dear B-COM-Z-MAS, I can certainly assist you with this for the following countries, Australia, Belgi...

          3.7 Hours Later
        3. Profile Picture

          Shrinivas |CEO

          I can handle this project since we are into it for major MNCs . Rgds Shrinivas.Muthangi...

          17.9 Hours Later
        +9 Other Responses
        Area Icon

        Global Pharmaceuticals

        Hi zintro expert, the zintro blog needs you! *a brief answer to the prompt about 1-2 paragraphs including your full name *participation is voluntary no payment will be involved *if chosen, you will be named in the post and we'll include a link to your zintro profile which will generate more visitors for you topic and prompt global pharmaceuticals companies have seen an improvement in their drugs pipelines but the industry is facing a fresh challenge as the first generation of blockbuster biological drugs begins to face competition. Bristol-myers squibb and eli lilly have the strongest late-stage pipelines relative to existing revenues, while astrazeneca has shown the greatest improvement over the past two years, says a report by credit rating agency moody’s. However, those same three companies also face the greatest exposure to patent expiries over the next three years, highlighting the perennial battle faced by drugmakers to develop new medicines as old ones lose market exclusivity. What are your thoughts? Getting your name and expert opinion published on our blog is a great marketing opportunity. If interested, please send a response to the prompt via znotes within 1-2 days. Don't forget to include your full name. If you have any questions, please let us know. Thank you! the zintro blog team wondering what the post would look like? Here is a sample: http://blog.Zintro.Com/2014/08/14/rosetta-completes-10-year-trip-deep-space />

        1. Profile Picture

          Dr Sumant |Biopharma Biologics Process and Manufact

          New biological molecules development is very important to sustain the pharma market in future decade...

          4.1 Hours Later
        2. Profile Picture

          Sanjeev |Consultant

          I think that near *****ry of drugs need to be aligned with pricing adjustments so as these com...

          4.8 Hours Later
        3. Profile Picture

          Umberto |Previously: COO, VP & Director Regulator

          This is the plight of big pharma. How do you keep the pipeline fresh: ***** discover new...

          17.2 Hours Later
        +4 Other Responses
        Area Icon

        Pharmaceutical Industry

        Hi zintro expert,the zintro blog needs you! we are looking for expert opinions on the news mentioned below and would like to include your point of view.  we realize your time is valuable, so here is a brief summary of what we are looking for: *a brief answer to the prompt about 1-2 paragraphs including your full name*participation is voluntary no payment will be involved*if chosen, you will be named in the post and we'll include a link to your zintro profile which will generate more visitors for you topic and prompt teva pharmaceutical industries ltd. And active biotech ab said monday they were ending the higher-dose portions of two multiple-sclerosis studies with the drug laquinimod after eight patients suffered nonfatal cardiovascular events.The companies said the incidents occurred in the higher-dose components of a phase 3 and a phase 2 clinical trial. The lower-dose and placebo components of the tests will continue.Phase 3 clinical trials are typically the last phase before a drug gets approval from the u.S. Food and drug administration.Teva shares fell 1.3% in early trading in new york, and active biotech shares fell by about one-third in stockholm.Laquinimod is a once-daily oral drug being developed for treating multiple sclerosis and huntington disease. What are your thoughts? Getting your name and expert opinion published on our blog is a great marketing opportunity. if interested, please send a response to the prompt via znotes within 1-2 days.Don't forget to include your full name.If you have any questions, please let us know.Thank you! the zintro blog team wondering what the post would look like? Here is a sample: http://blog.Zintro.Com/2014/08/14/rosetta-completes-10-year-trip-deep-space/>

        1. Profile Picture

          Balkrishna |Zintro Expert

          My linkedin profile can be viewed to get details about my background in industry.You can contact me ...

          6.2 Hours Later
        2. Profile Picture

          Polina |Zintro Expert

          I am interested in contributing. Please let me know what it involves....

          7.2 Hours Later
        3. Profile Picture

          Jacob |President/CEO

          The incidents described are typical when testing a drug in the advanced stages of phase 2 and 3. at ...

          17.6 Hours Later
        +7 Other Responses
        See More Inquiries

        designed to encourage the development of drugs which are necessary but would be prohibitively expensive/un-profitable to develop under normal circumstances

        Top Orphan Drugs Experts

        See More Experts
        Share
        LinkedInTwitterFacebookGoogle+